X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs PANACEA BIOTECH - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD PANACEA BIOTECH ALEMBIC LTD/
PANACEA BIOTECH
 
P/E (TTM) x 51.7 -6.6 - View Chart
P/BV x 2.1 2.1 98.6% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 ALEMBIC LTD   PANACEA BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
PANACEA BIOTECH
Mar-14
ALEMBIC LTD/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs72149 48.4%   
Low Rs3482 41.2%   
Sales per share (Unadj.) Rs4.784.1 5.6%  
Earnings per share (Unadj.) Rs6.1-18.3 -33.3%  
Cash flow per share (Unadj.) Rs6.2-6.7 -93.2%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.783.7 48.6%  
Shares outstanding (eoy) m267.0361.25 436.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.4 820.6%   
Avg P/E ratio x8.7-6.3 -137.5%  
P/CF ratio (eoy) x8.5-17.2 -49.2%  
Price / Book Value ratio x1.31.4 94.4%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1397,074 199.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2071,449 14.3%   
Avg. sales/employee Rs ThNM1,874.1-  
Avg. wages/employee Rs ThNM527.0-  
Avg. net profit/employee Rs ThNM-407.7-  
INCOME DATA
Net Sales Rs m1,2555,154 24.4%  
Other income Rs m370100 370.9%   
Total revenues Rs m1,6255,254 30.9%   
Gross profit Rs m111-766 -14.5%  
Depreciation Rs m38711 5.3%   
Interest Rs m21,503 0.1%   
Profit before tax Rs m442-2,881 -15.3%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m1,212-6 -21,263.2%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m2417 142.6%   
Profit after tax Rs m1,630-1,121 -145.4%  
Gross profit margin %8.9-14.9 -59.5%  
Effective tax rate %5.4-0.6 -929.5%   
Net profit margin %129.8-21.8 -596.8%  
BALANCE SHEET DATA
Current assets Rs m1,8673,810 49.0%   
Current liabilities Rs m5918,365 7.1%   
Net working cap to sales %101.6-88.4 -115.0%  
Current ratio x3.20.5 693.4%  
Inventory Days Days94156 60.5%  
Debtors Days Days7467 109.4%  
Net fixed assets Rs m1,79114,480 12.4%   
Share capital Rs m53461 871.3%   
"Free" reserves Rs m10,324903 1,143.1%   
Net worth Rs m10,8585,127 211.8%   
Long term debt Rs m415,832 0.7%   
Total assets Rs m11,59119,433 59.6%  
Interest coverage x260.9-0.9 -28,465.1%   
Debt to equity ratio x01.1 0.3%  
Sales to assets ratio x0.10.3 40.8%   
Return on assets %14.12.0 716.7%  
Return on equity %15.0-21.9 -68.6%  
Return on capital %15.23.6 417.7%  
Exports to sales %1.524.5 6.3%   
Imports to sales %21.010.2 206.0%   
Exports (fob) Rs m191,264 1.5%   
Imports (cif) Rs m263525 50.2%   
Fx inflow Rs m191,539 1.3%   
Fx outflow Rs m264942 28.0%   
Net fx Rs m-244597 -40.9%   
CASH FLOW
From Operations Rs m236599 39.4%  
From Investments Rs m-224-438 51.2%  
From Financial Activity Rs m-27-303 8.8%  
Net Cashflow Rs m-15-141 10.5%  

Share Holding

Indian Promoters % 64.0 74.5 85.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.6 33.3%  
FIIs % 9.7 1.3 746.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 23.6 110.6%  
Shareholders   54,701 10,259 533.2%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Feb 22, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS